HomeCompareKCAP vs HUM

KCAP vs HUM: Dividend Comparison 2026

KCAP yields 4.00% · HUM yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HUM wins by $61.3K in total portfolio value· pulled ahead in Year 3
10 years
KCAP
KCAP
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full KCAP calculator →
HUM
HUM
● Live price
2.13%
Share price
$166.00
Annual div
$3.54
5Y div CAGR
46.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$89.4K
Annual income
$29,002.59
Full HUM calculator →

Portfolio growth — KCAP vs HUM

📍 HUM pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKCAPHUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KCAP + HUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KCAP pays
HUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KCAP
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
HUM
Annual income on $10K today (after 15% tax)
$181.27/yr
After 10yr DRIP, annual income (after tax)
$24,652.20/yr
At 15% tax rate, HUM beats the other by $23,887.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KCAP + HUM for your $10,000?

KCAP: 50%HUM: 50%
100% HUM50/50100% KCAP
Portfolio after 10yr
$58.7K
Annual income
$14,950.90/yr
Blended yield
25.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on HUM right now

KCAP
No analyst data
HUM
Analyst Ratings
14
Buy
27
Hold
2
Sell
Consensus: Hold
Price Target
$235.00
+41.6% upside vs current
Range: $146.00 — $345.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KCAP buys
0
HUM buys
13
PoliticianChamberTickerTypeAmountDate
Julia Letlow🏢 House$HUM▼ Sell$1,001 - $15,0002026-02-10
Gilbert Cisneros🏢 House$HUM▼ Sell$1,001 - $15,0002025-11-12
Michael McCaul🏢 House$HUM▼ Sell$15,001 - $50,0002025-11-04
Lisa McClain🏢 House$HUM▲ Buy$1,001 - $15,0002025-09-25
Julia Letlow🏢 House$HUM▲ Buy$1,001 - $15,0002025-08-08
Gilbert Cisneros🏢 House$HUM▲ Buy$1,001 - $15,0002025-08-05
Ro Khanna🏢 House$HUM▲ Buy$1,001 - $15,0002025-07-25
Lisa McClain🏢 House$HUM▲ Buy$1,001 - $15,0002025-06-24
Gilbert Cisneros🏢 House$HUM▼ Sell$1,001 - $15,0002025-05-30
Gilbert Cisneros🏢 House$HUM▼ Sell$1,001 - $15,0002025-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKCAPHUM
Forward yield4.00%2.13%
Annual dividend / share$2.00$3.54
Payout ratio50%50%
1-year div growth5%0%
5-year div CAGR5%46.1%
Portfolio after 10y$28.0K$89.4K
Annual income after 10y$899.19$29,002.59
Total dividends collected$6.4K$63.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KCAP vs HUM ($10,000, DRIP)

YearKCAP PortfolioKCAP Income/yrHUM PortfolioHUM Income/yrGap
1$11,120$420.00$11,012$311.56+$108.00KCAP
2$12,357$458.31$12,251$468.45+$106.00KCAP
3← crossover$13,721$499.76$13,820$711.61$99.00HUM
4$15,227$544.58$15,883$1,096.11$656.00HUM
5$16,885$593.02$18,715$1,720.11$1.8KHUM
6$18,713$645.34$22,793$2,767.44$4.1KHUM
7$20,724$701.81$28,990$4,601.98$8.3KHUM
8$22,938$762.73$39,012$7,992.19$16.1KHUM
9$25,372$828.41$56,428$14,685.03$31.1KHUM
10$28,047$899.19$89,380$29,002.59$61.3KHUM

KCAP vs HUM: Complete Analysis 2026

KCAPStock

KCAP is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in KCAP shares.

Full KCAP Calculator →

HUMHealthcare

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Full HUM Calculator →
📬

Get this KCAP vs HUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KCAP vs SCHDKCAP vs JEPIKCAP vs OKCAP vs KOKCAP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.